Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

7 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Effect of the topical administration of N-(2-(4-bromophenylamino)-5-(trifluoromethyl)phenyl)nicotinamide compound in a murine subcutaneous melanoma model.
Vale JAD, de Souza APM, Lima GDA, Gonçalves VHS, Moreira GA, Barros MVA, Pereira WL, Merchid NCLE, Fietto JLR, Bressan GC, Teixeira RR, Machado-Neves M. Vale JAD, et al. Among authors: barros mva. Anticancer Drugs. 2020 Aug;31(7):718-727. doi: 10.1097/CAD.0000000000000944. Anticancer Drugs. 2020. PMID: 32568827
Potential Antileukemia Effect and Structural Analyses of SRPK Inhibition by N-(2-(Piperidin-1-yl)-5-(Trifluoromethyl)Phenyl)Isonicotinamide (SRPIN340).
Siqueira RP, Barbosa Éde A, Polêto MD, Righetto GL, Seraphim TV, Salgado RL, Ferreira JG, Barros MV, de Oliveira LL, Laranjeira AB, Almeida MR, Júnior AS, Fietto JL, Kobarg J, de Oliveira EB, Teixeira RR, Borges JC, Yunes JA, Bressan GC. Siqueira RP, et al. PLoS One. 2015 Aug 5;10(8):e0134882. doi: 10.1371/journal.pone.0134882. eCollection 2015. PLoS One. 2015. PMID: 26244849 Free PMC article.
Trifluoromethyl arylamides with antileukemia effect and intracellular inhibitory activity over serine/arginine-rich protein kinases (SRPKs).
Siqueira RP, Barros MVA, Barbosa ÉAA, Onofre TS, Gonçalves VHS, Pereira HS, Silva Júnior A, de Oliveira LL, Almeida MR, Fietto JLR, Teixeira RR, Bressan GC. Siqueira RP, et al. Among authors: barros mva. Eur J Med Chem. 2017 Jul 7;134:97-109. doi: 10.1016/j.ejmech.2017.03.078. Epub 2017 Mar 31. Eur J Med Chem. 2017. PMID: 28407594
Antimetastatic effect of the pharmacological inhibition of serine/arginine-rich protein kinases (SRPK) in murine melanoma.
Moreira GA, Lima GDA, Siqueira RP, Barros MVA, Adjanohoun ALM, Santos VC, Barbosa ÉAA, Loterio RK, Paiva JC, Gonçalves VHS, Viol LCS, Marques-da-Silva EA, Júnior AS, Almeida MR, Fietto JLR, Machado-Neves M, Ferreira RS, Teixeira RR, Bressan GC. Moreira GA, et al. Among authors: barros mva. Toxicol Appl Pharmacol. 2018 Oct 1;356:214-223. doi: 10.1016/j.taap.2018.08.012. Epub 2018 Aug 20. Toxicol Appl Pharmacol. 2018. PMID: 30138656 Free article.
Combined SRPK and AKT pharmacological inhibition is synergistic in T-cell acute lymphoblastic leukemia cells.
Siqueira RP, Caetano MMM, de Souza LÂ, Dos Passos PMS, Simaroli NB, Barros MVA, de Souza APM, de Oliveira LL, Silva-Júnior A, Fietto JLR, Teixeira RR, Teixeira FR, Bressan GC. Siqueira RP, et al. Among authors: barros mva. Toxicol In Vitro. 2020 Jun;65:104777. doi: 10.1016/j.tiv.2020.104777. Epub 2020 Jan 18. Toxicol In Vitro. 2020. PMID: 31962201 Free article.
First evidence of a serine arginine protein kinase (SRPK) in leishmania braziliensis and its potential as therapeutic target.
Pimentel DC, Leopoldo JR, Teixeira LF, Barros MVA, de Souza APM, Onofre TS, de Carvalho RL, Machado SA, Messias IG, Pinto CCS, Poleto MD, Diogo MA, Mariotini-Moura C, Bressan GC, Teixeira RR, Fietto JLR, Vasconcellos RS. Pimentel DC, et al. Among authors: barros mva. Acta Trop. 2023 Feb;238:106801. doi: 10.1016/j.actatropica.2022.106801. Epub 2022 Dec 20. Acta Trop. 2023. PMID: 36563831